COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pemetrexed for the Treatment of Chordoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03955042
Recruitment Status : Recruiting
First Posted : May 17, 2019
Last Update Posted : October 2, 2019
Eli Lilly and Company
Chordoma Foundation
Information provided by (Responsible Party):
Santosh Kesari, John Wayne Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : May 31, 2023